NPI: 1760789903 · POPLARVILLE, MS 39470 · Critical Access Hospital · NPI assigned 02/24/2011
Authorized official HESTER, BEN controls 20+ related entities in our dataset. Read more
| Authorized Official | HESTER, BEN (CFO) |
| Parent Organization | FORREST COUNTY GENERAL HOSPITAL |
| NPI Enumeration Date | 02/24/2011 |
Other providers sharing the same authorized official: HESTER, BEN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,242 | $562K |
| 2019 | 16,514 | $578K |
| 2020 | 8,440 | $291K |
| 2021 | 8,328 | $421K |
| 2022 | 14,571 | $581K |
| 2023 | 16,095 | $736K |
| 2024 | 12,591 | $570K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 8,659 | 7,012 | $1.16M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,901 | 2,346 | $477K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,128 | 2,721 | $265K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 857 | 653 | $207K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,624 | 1,361 | $159K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2,587 | 2,129 | $151K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8,642 | 559 | $150K |
| 87634 | 2,562 | 2,110 | $110K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1,130 | 967 | $98K |
| 71046 | Radiologic examination, chest; 2 views | 2,247 | 1,844 | $94K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,604 | 2,135 | $82K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 932 | 785 | $82K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 5,482 | 451 | $75K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,788 | 1,435 | $60K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,529 | 1,376 | $50K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,906 | 1,575 | $45K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,987 | 1,637 | $44K |
| 71045 | Radiologic examination, chest; single view | 1,077 | 888 | $41K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6,399 | 4,938 | $34K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 227 | 68 | $33K |
| 80053 | Comprehensive metabolic panel | 4,259 | 3,486 | $32K |
| 96361 | Intravenous infusion, hydration; each additional hour | 875 | 749 | $25K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 241 | 187 | $24K |
| 97116 | 1,977 | 196 | $23K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 809 | 631 | $18K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,414 | 909 | $17K |
| 87428 | 306 | 266 | $14K | |
| 80305 | 916 | 876 | $12K | |
| 84443 | Thyroid stimulating hormone (TSH) | 891 | 803 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,717 | 1,319 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 390 | 349 | $10K |
| 36415 | Collection of venous blood by venipuncture | 4,394 | 3,012 | $10K |
| 84484 | 1,316 | 1,031 | $9K | |
| 83880 | 492 | 409 | $9K | |
| 81001 | 3,602 | 2,998 | $9K | |
| 80061 | Lipid panel | 705 | 633 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | 692 | 605 | $5K |
| 81025 | 701 | 604 | $5K | |
| 83690 | 1,069 | 902 | $5K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 403 | 59 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 27 | 25 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 351 | 301 | $4K |
| 87430 | 322 | 298 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 39 | 37 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 578 | 463 | $4K |
| 73630 | 66 | 56 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 37 | 25 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 71 | 58 | $3K |
| 97597 | 37 | 12 | $2K | |
| 87807 | 172 | 152 | $2K | |
| 80076 | 292 | 263 | $2K | |
| 82150 | 413 | 351 | $2K | |
| 97161 | 57 | 41 | $2K | |
| 82607 | 126 | 115 | $2K | |
| 36592 | 1,221 | 1,034 | $2K | |
| 82553 | 292 | 245 | $2K | |
| 87081 | 303 | 279 | $1K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 49 | 12 | $1K |
| 93000 | 35 | 31 | $1K | |
| 0012A | 49 | 48 | $1K | |
| 87186 | 158 | 103 | $1K | |
| 82550 | 327 | 265 | $996.14 | |
| G0008 | Administration of influenza virus vaccine | 19 | 13 | $951.90 |
| 0011A | 71 | 60 | $941.21 | |
| 73130 | 14 | 14 | $881.24 | |
| J1741 | Injection, ibuprofen, 100 mg | 23 | 12 | $787.00 |
| 73610 | 23 | 15 | $752.76 | |
| A9150 | Non-prescription drugs | 14 | 12 | $750.00 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 20 | 12 | $705.74 |
| 83735 | 109 | 98 | $679.97 | |
| 90791 | Psychiatric diagnostic evaluation | 19 | 13 | $649.25 |
| 97166 | 12 | 12 | $558.84 | |
| 85378 | 118 | 106 | $518.01 | |
| 85610 | 179 | 110 | $470.87 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 14 | 13 | $393.25 |
| 87420 | 28 | 27 | $310.00 | |
| 80176 | 17 | 17 | $229.04 | |
| 82746 | 14 | 14 | $228.76 | |
| 84439 | 24 | 24 | $169.31 | |
| 85730 | 75 | 51 | $167.82 | |
| 87070 | 17 | 16 | $117.54 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,220 | 1,024 | $111.69 |
| 94664 | 154 | 109 | $94.25 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 602 | 494 | $89.28 |
| 83615 | 13 | 13 | $87.23 | |
| 87077 | 15 | 12 | $73.66 | |
| 87040 | 18 | 13 | $65.03 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 14 | 14 | $57.80 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 186 | 154 | $23.40 |
| 97535 | Self-care/home management training, each 15 minutes | 373 | 75 | $16.78 |
| 85379 | 24 | 24 | $9.16 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 20 | 14 | $7.80 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 210 | 104 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 116 | 62 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 274 | 134 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 175 | 86 | $0.00 |
| A9270 | Non-covered item or service | 83 | 68 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 15 | 14 | $0.00 |